MeiraGTx Holdings (MGTX) Net Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) posted Net Margin of 20.02% for Q4 2025, up 100.16% on a QoQ basis from 12320.24% in Q3 2025, and up 20421.0% year-over-year from N/an in Q4 2024.
MeiraGTx Holdings (MGTX) Net Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings' Net Margin history runs 7 years deep, the most recent figure standing at 20.02% for Q4 2025.
- Quarterly Net Margin rose 20421.0% year-over-year to 20.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 113.23% (up 33086.0% YoY) and the FY2025 annual result came in at 140.31%, up 30379.0% from the prior year.
- Net Margin was 20.02% for Q4 2025 at MeiraGTx Holdings, up from 12320.24% in the prior quarter.
- Across five years, Net Margin topped out at 990.93% in Q4 2023 and bottomed at 17241.13% in Q2 2024.
- A 5-year average of 2007.64% and a median of 513.97% in 2021 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin tumbled 1640551 bps — and 2025, when it surged 1619006 bps.
- MeiraGTx Holdings' Net Margin stood at 47.1% in 2021, then jumped by 1197 bps to 516.51% in 2022, then jumped by 92 bps to 990.93% in 2023, then tumbled by 119 bps to 184.19% in 2024, then jumped by 111 bps to 20.02% in 2025.
- Business Quant data shows MGTX's Net Margin at 20.02% in Q4 2025, 12320.24% in Q3 2025, and 1051.07% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 20.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.02% |
| Sep 30, 2025 | -12,320.24% |
| Jun 30, 2025 | -1,051.07% |
| Dec 31, 2024 | -184.19% |
| Sep 30, 2024 | -360.49% |
| Jun 30, 2024 | -17,241.13% |
| Mar 31, 2024 | -2,932.86% |
| Dec 31, 2023 | 990.93% |
| Sep 30, 2023 | -868.06% |
| Jun 30, 2023 | -835.62% |
| Mar 31, 2023 | -910.74% |
| Dec 31, 2022 | 516.51% |
| Sep 30, 2022 | -774.17% |
| Jun 30, 2022 | -315.76% |
| Mar 31, 2022 | -551.13% |
| Dec 31, 2021 | -47.10% |
| Sep 30, 2021 | -373.42% |
| Jun 30, 2021 | -392.61% |
| Mar 31, 2021 | -513.97% |
| Dec 31, 2020 | -276.16% |